Suicidal ideation in prostate cancer survivors: Understanding the role of physical and psychological health outcomes
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Epidemiological studies have shown prostate cancer (PC) survivors are at an increased risk of suicide compared with the general population, but to the authors' knowledge very little is known regarding what factors are associated with this increased risk. The current study examined the prevalence of suicidal ideation (SI) and its association with cancer treatment and posttreatment physical and emotional health in a cohort of long‐term PC survivors. METHODS: A total of 693 PC survivors (3‐8 years after diagnosis) completed a mailed survey on physical and psychological functioning, including cancer treatments, the Short Form‐12 (SF‐12), the Expanded Prostate Cancer Index Composite Instrument (EPIC‐26), a depression rating scale, and 8 items regarding recent suicidal thoughts and behaviors. RESULTS: A total of 86 PC survivors (12.4%) endorsed SI, with 10 individuals (1.4%) reporting serious SI. Serious SI was more common in this sample compared with age‐adjusted and sex‐adjusted normative data. SI was not associated with most demographic variables, or with PC stage or treatments. However, SI was found to be significantly associated with employment status, poor physical and emotional functioning, greater symptom burden on the EPIC‐26, higher frequency of significant pain, and clinically significant depression (P < .01). In an adjusted logistic model, poor physical and emotional function, including disability status and pain, were found to be associated with SI (P < .05), even after adjusting for depression. CONCLUSIONS: A significant percentage of PC survivors report recent SI, which is associated with both physical and psychological dysfunction, but not PC treatments. The results of the current study help to explain the increased risk of suicide previously reported in PC survivors and have important implications for identifying and treating those survivors at greatest risk of suicidality. Cancer 2014;120:3393–3400. © 2014 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wei, J. T., Dunn, R. L., Litwin, M. S., Sandler, H. M., & Sanda, M. G. (2000) · Urology · doi:10.1016/s0090-4295(00)00858-x · Cited by 1,520 · cited 3×
“PC-related symptoms were evaluated using the Expanded Prostate Cancer Index Composite Instrument (EPIC-26), a 26-item questionnaire inquiring about symptoms associated with PC treatment in 4 domains (urinary, bowel, sexual, and hormonal) and previously validated in studies of patients with PC.21 Health-related quality…”
MethodIncidence of Suicide in Persons With Cancer
Misono, S., Weiss, N. S., Fann, J. R., Redman, M., & Yueh, B. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.8941 · Cited by 608
Conwell, Y., & Thompson, C. (2008) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2008.01.004 · Cited by 333
A risk index for 12-month suicide attempts in the National Comorbidity Survey Replication (NCS-R)
BORGES, G., ANGST, J., NOCK, M. K., RUSCIO, A. M., WALTERS, E. E., & KESSLER, R. C. (2006) · Psychological Medicine · doi:10.1017/s0033291706008786 · Cited by 246
Joiner, T. E., Steer, R. A., Brown, G., Beck, A. T., Pettit, J. W., & Rudd, M. D. (2003) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(03)00070-6 · Cited by 215
The risk of suicide in cancer patients: a review of the literature
Robson, A., Scrutton, F., Wilkinson, L., & MacLeod, F. (2010) · Psycho-Oncology · doi:10.1002/pon.1717 · Cited by 199
Better Off Dead: Suicidal Thoughts in Cancer Patients
Walker, J., Waters, R. A., Murray, G., Swanson, H., Hibberd, C. J., Rush, R. W., Storey, D. J., Strong, V. A., Fallon, M. T., Wall, L. R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.8844 · Cited by 195
Psychosocial treatments of suicidal behaviors: A practice‐friendly review
Comtois, K. A., & Linehan, M. M. (2006) · Journal of Clinical Psychology · doi:10.1002/jclp.20220 · Cited by 139
Cited by
Ross, S., Agin-Liebes, G., Lo, S., Zeifman, R. J., Ghazal, L., Benville, J., Franco Corso, S., Bjerre Real, C., Guss, J., Bossis, A., et al. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00020 · Cited by 139
Kolva, E., Hoffecker, L., & Cox-Martin, E. (2020) · Palliative and Supportive Care · doi:10.1017/s1478951519000610 · Cited by 108
“, 2017), a historical or current psychiatric diagnosis (Madeira et al., 2011; Recklitis et al., 2014; Shim & Park, 2012; Spencer et al., 2012; Trevino, Balboni, Zollfrank, Balboni & Prigerson, 2014) and poorer psychological well-being (Cheng et al.”
BackgroundInfluentialFactors associated with suicide in patients with genitourinary malignancies
Klaassen, Z., Jen, R. P., DiBianco, J. M., Reinstatler, L., Li, Q., Madi, R., Lewis, R. W., Smith, A. M., Neal, D. E., Moses, K. A., et al. (2015) · Cancer · doi:10.1002/cncr.29274 · Cited by 95
“4% of patients have suicidal ideation.(14,15,25) The current study found that prostate cancer had the third highest incidence of suicide among the 5 genitourinary malignancies.”
BackgroundRiedl, D., & Schüßler, G. (2022) · Translational Oncology · doi:10.1016/j.tranon.2021.101328 · Cited by 77
“[43] Prostate survivors (n = 693) Longitudinal 3–8 years after diagnosis GDS-15 BDI High Increased risk for suicidal ideation: disabled (OR=3.”
BackgroundResultInfluentialHenry, M., Rosberger, Z., Bertrand, L., Klassen, C., Hier, M., Zeitouni, A., Kost, K., Mlynarek, A., Richardson, K., Black, M., et al. (2018) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599818776873 · Cited by 76
Metadata
- Authors
- Recklitis, C. J., Zhou, E. S., Zwemer, E. K., Hu, J. C., & Kantoff, P. W.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2014-06-24
- Volume
- 120
- Issue
- 21
- Pages
- 3393-3400
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1521287279
- Cited by
- 59
- References
- 8
- FWCI
- 2.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.